1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Structural and functional brain alterations in patients with myasthenia gravis, 2022, Klaus et al.

Discussion in 'Other health news and research' started by SNT Gatchaman, Feb 22, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,456
    Location:
    Aotearoa New Zealand
    Structural and functional brain alterations in patients with myasthenia gravis
    Klaus, Benita; Müller, Patrick; van Wickeren, Nora; Dordevic, Milos; Schmicker, Marlen; Zdunczyk, Yael; Brigadski, Tanja; Leßmann, Volkmar; Vielhaber, Stefan; Schreiber, Stefanie; Müller, Notger G.

    Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients.

    Eleven myasthenia gravis patients (age: 70.64 + 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 + 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T1 weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels.

    Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040).

    Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe.

    Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail.

    Link | PDF (Brain Communications)
     
    Sean, Milo, Lindberg and 1 other person like this.

Share This Page